CST, Mawhiba Announce Saudi Arabia's First Ever Participation in IOAA 2024 in Brazil

CST, Mawhiba Announce Saudi Arabia's First Ever Participation in IOAA 2024 in Brazil
TT

CST, Mawhiba Announce Saudi Arabia's First Ever Participation in IOAA 2024 in Brazil

CST, Mawhiba Announce Saudi Arabia's First Ever Participation in IOAA 2024 in Brazil

The Communications, Space and Technology Commission (CST) announced the first ever participation of the Saudi Astronomy Team in the International Olympiad on Astronomy and Astrophysics (IOAA 2024) in Brazil.

The move is in collaboration with the King Abdulaziz and His Companions Foundation for Giftedness and Creativity (Mawhiba).

The achievement is a product of CST and Mawhiba's joint programs that included training and preparing students.

The Saudi Astronomy Team will be represented by Jude Basem Al-Luhyani from the Makkah Education Department, Fajr Hassan Al-Obaidan from the Al-Ahsa Education Department, and Hussein Hassan Al-Mubarak from the Eastern Province Education Department.

Each member has undergone around 590 hours of training.

Their participation reflects CST's commitment to nurturing national talent for global competition in the space sector, empowering local individuals, and motivating students to pursue careers in space and related fields, all aimed at strengthening Saudi Arabia’s capabilities in the space industry.

CST has implemented a series of training programs over a 12-month period. This initiative was designed in collaboration with Mawhiba to prepare students for the IOAA 2024, which assesses participants' skills in astronomical observation, celestial mechanics, astrophysics, and cosmology.

As a regulator in the space sector, CST is committed to offering a variety of training and educational programs. These initiatives aim to prepare national cadres to keep up with rapid developments in space and to boost opportunities in the field.



Bavarian Nordic to Ramp up Production of Mpox Vaccine

An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo Purchase Licensing Rights
An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo Purchase Licensing Rights
TT

Bavarian Nordic to Ramp up Production of Mpox Vaccine

An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo Purchase Licensing Rights
An employee of the vaccine company Bavarian Nordic works in a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. REUTERS/Lukas Barth/File Photo Purchase Licensing Rights

Danish biotech firm Bavarian Nordic said on Saturday it plans to ramp up production of its mpox vaccine and work with international health organizations to ensure fair access as the disease has been declared a global public health emergency.

The company, one of the few drug firms that have an mpox vaccine, said it has informed the Africa Centers for Disease Control and Prevention (CDC) that it can manufacture 10 million doses of the vaccine by the end of 2025, and could already supply up to 2 million doses this year.

The company said that it is expanding its production network to include Africa, and is prepared to work with Africa CDC as well as the World Health Organization (WHO) to make the vaccine accessible to all countries, Reuters reported.

Earlier this week, the WHO declared mpox a global public health emergency for the second time in two years.

The viral infection, which causes pus-filled lesions and flu-like symptoms, is usually mild but can kill. Two strains are now spreading in Congo and neighboring countries - the endemic form of the virus, clade I, and a new offshoot called clade Ib.

There have been 27,000 cases and more than 1,100 deaths, mainly among children, in Congo since the current outbreak began in January 2023.